R&D Nederland tegen de trend in omlaag

Nieuws | de redactie
18 november 2009 | Huiswerk voor de president van Europa? Terwijl Nederlandse bedrijven bezuinigen op hun innovatie-investeringen, is de trend elders in Europa en wereldwijd precies de omgekeerde. Kost en baet, het oud-hollandse gezegde gaat weer buiten ons land op: +8% elders in de EU.

BRIC’s booming in R&D

Worldwide spending on corporate R&D increased by 6.9% in2008, according to the EU Industrial R&D InvestmentScoreboard.For companies with their headquarters in the EU,investment growth was 8.1% higher than the previous year. This wasa significantly greater increase than the 5.7% growth recorded byUS firms and the 4.4% increase recorded in Japan. 

Two European companies feature in the top ten forindustrial R&D investment, with Volkswagen coming in thirdplace and Nokia coming eighth. Topping the table was Toyota, whichspent €7.61 billion.  US firms were, on average, moreconservative than their European competitors, but American firmsstill account for half of the top ten corporations when it comes toR&D investment: namely Microsoft, General Motors, Pfizer,Ford and Johnson & Johnson. Switzerland also had two companiesin the top tier – Roche and Novartis. 

Companies based in emerging economies continued to show thehighest R&D growth, led by China with a 40% increase, India(27.3%), Taiwan (25.1%) and Brazil (18.6%). This is line withexpectations that China and India could overtake Europe and the USto become world leaders in research by 2025. While R&D spendingmay have remained robust in 2008, the Scoreboard also providesdetails of company operating profits, which fell by 30.5% in the EUand 19.1% in the US. 

Pharma and biotech lead the way 

Research growth in the US is dominatedby knowledge-intensive sectors, includingpharmaceuticals, biotechnology and IT, while R&D growth inthe EU is more evenly spread across all sectors. 

EU companies lead the way in the medium-high and medium-lowR&D intensity areas, such as the car parts, electricalequipment and chemicals sectors. The pharmaceuticals andbiotechnology sector reinforces its position as the topR&D investor both worldwide and in the US, accounting for 18.9%and 25% respectively. 

The automobiles and parts sector is the thirdbiggest worldwide, accounting for 17.1%, but the first in EUand Japan, accounting for 25% and 27% respectively. Despite beingthe first sector to be hit by the economic crisis, someautomobile companies recorded double-digit R&D growth inthe past year. 

This year’s Scoreboard also confirms the strong R&D activityof companies active in renewable energy technologies. The six EUcompanies from this sector showed impressive growth in R&Dinvestment over the last three years. (bron:Euractiv) 

Schrijf je in voor onze nieuwsbrief
ScienceGuide is bij wet verplicht je toestemming te vragen voor het gebruik van cookies.
Lees hier over ons cookiebeleid en klik op OK om akkoord te gaan